Spectrum Vascular
Martin Gargiule is a seasoned finance executive with extensive experience in various leadership roles across multiple organizations. Currently serving as VP Finance & Corporate Controller at Spectrum Vascular, Martin has held prominent positions such as Member of the Board of Directors at Scienture Inc. and Consultant - Interim Controller at Armas Pharmaceuticals. Previous roles include Chief Financial Officer at Douglas Electrical Components, VP of Finance at Advantice Health, and VP Finance – Financial Planning & Analysis at Amneal Pharmaceuticals. Martin’s career also encompasses significant financial positions at G&W Laboratories, Sandoz, Mylan Pharmaceuticals, and Deloitte, where Martin demonstrated expertise in accounting, financial reporting, and strategic planning. Martin holds a Bachelor of Science in Accounting and a Bachelor of Arts in Business Administration from Slippery Rock University of Pennsylvania.
This person is not in any teams
Spectrum Vascular
1 followers
Spectrum Vascular is a medical device company focused on vascular access and medication management. The company's mission is to improve the lives of patients worldwide by providing caregivers with high quality, innovative products with exceptional customer service. Innovation has been a core strategic pillar throughout Spectrum Vascular's history and many of its products have been designed to deliver antimicrobial protection and thrombus reduction. Spectrum Vascular is a portfolio company of Event Capital Strategies, a medical technology-focused investment fund based in New York.